HEALWELL AI’s Pentavere Partners with Sunnybrook and Successfully Demonstrates its AI Powered Clinician Co-pilot System Can Improve Cancer Staging in Prestigious Peer-Reviewed Medical Journal

• Pentavere partnered with Sunnybrook Health Sciences Centre to demonstrate how Pentavere’s DARWEN AI platform can help enhance cancer staging to improve patient outcomes.
  
• Results of this collaboration were presented at the prestigious American Head and Neck Society annual conference and published in JAMA Otolaryngology, which is the highest impact journal for Otolaryngologic or ‘head and neck’ cancers.
• This is the first published paper of its kind demonstrating artificial intelligence analyzing unstructured clinical text within electronic health records to accurately support the automation and acceleration of cancer staging for complex head and neck cancers.
  

TORONTO, May 21, 2024 (GLOBE NEWSWIRE) -- HEALWELL AI Inc. (“HEALWELL” or the “Company”) (TSX: AIDX) (OTCQX: HWAIF), a data science and AI company focused on preventative care, is pleased to announce that its subsidiary Pentavere Research Group Inc. (“Pentavere”), has partnered with Sunnybrook Health Sciences Centre and Dr. Tony Eskander, a globally recognized head and neck surgical oncologist to demonstrate how Pentavere’s DARWEN AI platform can help improve cancer staging to support treatment decisions and improve patient outcomes.

• Results of this collaboration were presented at the prestigious American Head and Neck Society annual conference and published in JAMA Otolaryngology, which is the highest impact journal for head and neck cancers.
  
• This is the first published paper of its kind demonstrating artificial intelligence analyzing unstructured clinical text within electronic health records to accurately support the automation and acceleration of cancer staging for complex head and neck cancers.  
  
• This work underscores the potential of AI in enhancing patient care and oncological decision-making and demonstrates the potential impact of AI powered clinical decision support as a Co-pilot to physicians to improve cancer patient outcomes.
  

Aaron Leibtag, Co-Founder and CEO at Pentavere, commented, “This exciting collaboration with Dr. Eskander and his team shows how Pentavere’s DARWEN AI platform has the ability to support the critical decision-making processes of clinicians ensuring they remain central to patient care and is further proof of our mission to be a leading AI Decision Support for disease detection and preventative care that is supported by peer reviewed validation and partnerships of the highest quality and reputation. To our knowledge this is the first validation of this nature ever published in a peer reviewed publication.”